Oct 29, 2025
The pharmaceutical industry is undergoing a paradigm shift, as Artificial Intelligence (AI) becomes a central force in transforming every stage of the drug lifecycle, from discovery to post-market performance. Among its most disruptive applications, AI in drug commercialization is redefining how therapies are...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper